| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Sep―07 |
Consequences of at-risk surgery in patients with SARS-CoV-2 infection |
Fatou Niang, Guillaume Ménard, Bay Karim Diallo, Birame Loum, Richard Edouard Alain Deguenonvo, Vincent Thibault, Pierre Tattevin |
| 2 |
[GO] |
2024―Aug―03 |
Discussion on ‘External validation of two clinical prediction models for mortality in COVID-19 patients (4C and NEWS2), in three centers in Medellín, Colombia: Assessing the impact of vaccination over time’ |
Hai-Feng Liu, Hong-Min Fu |
| 3 |
[GO] |
2024―Jul―02 |
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study |
Derrick Lopez, Douglas Pritchard, Frank M. Sanfilippo, Erin Kelty, Amy Page, Christopher Etherton-Beer, Osvaldo P. Almeida, David B. Preen |
| 4 |
[GO] |
2024―Jun―26 |
Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in France |
Christophe Perrey, Alexandra Mailles, Alexandra Septfons, Tiffany Charmet, Olivia Cheny, Cassandre Von Platen, Pauline Huet, Daniel Lévy-Bruhl, Simon Galmiche, Arnaud Fontanet, Marie Jauffret-Roustide |
| 5 |
[GO] |
2024―May―03 |
External validation of two clinical prediction models for mortality in COVID-19 patients (4C and NEWS2), in three centers in Medellín, Colombia: Assessing the impact of vaccination over time |
Paola Andrea Gallego Aristizabal, Tania Paola Lujan Chavarría, Sara Isabel Vergara Hernández, Federico Rincón Acosta, María Paula Sánchez Carmona, Paula Andrea Salazar Ospina, Carlos Jose Atencia Florez, Carlos Mario Barros Liñán, Fabián Jaimes |
| 6 |
[GO] |
2024―Apr―17 |
Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward? |
Victor Gerber, Louis Boehn, Marcela Sabou, Antoine Studer, Axel Ursenbach, Yves Hansmann, Raoul Herbrecht, Nicolas Lefebvre, Valérie Letscher-Bru, François Danion |
| 7 |
[GO] |
2024―Mar―16 |
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination |
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, Rebecca Bauer, Mikael Attia, Anne-Sophie Lecompte, Marie Lachatre, Zoha Maakaroun-Vermesse, Jean-François Nicolas, Renaud Verdon, Jean-Jacques Kiladjian, Paul Loubet, Catherine Schmidt-Mutter, Violaine Corbin, Séverine Ansart, Giovanna Melica, Martine Resch, Emmanuelle Netzer, Yousra Kherabi, Raphaëlle Tardieu, Jean-Daniel Lelièvre, Eric Tartour, Laurence Meyer, Xavier de Lamballerie, Odile Launay |
| 8 |
[GO] |
2024―Mar―16 |
One-year follow-up of COVID-19 recoverees with impaired pulmonary function: A prospective cohort study |
Nitzan Karny Epstein, Dana Yelin, Dorit Shitenberg, Dafna Yahav, Leonard Leibovici, Vered Daitch, Ili Margalit |
| 9 |
[GO] |
2024―Feb―02 |
Change of epidemiological characteristics of four respiratory viral infections in children before and during COVID-19 pandemic |
Dan Xu, Zhimin Chen, Guohong Zhu |
| 10 |
[GO] |
2024―Feb―02 |
Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infection |
Gauthier Lignier, Caroline Camaré, Thibaut Jamme, Marie-Sophie Combis, Didier Tayac, Françoise Maupas-Schwalm |
| 11 |
[GO] |
2023―Nov―18 |
Could the changes of immunity induced by SARS-CoV-2 infections explain the rebound of infectious disease after the relaxation of non-pharmaceutical interventions? |
Robert Cohen, Corinne Levy |
| 12 |
[GO] |
2023―Nov―15 |
Clinical Features and Outcomes in Adults with COVID-19 during the pre-Omicron and Omicron Waves |
M. Martinot, A. Schieber, J.C. Ongagna, A. Henric, M. Eyriey, M. Mohseni-Zadeh, C. Ion, K demesmay, S. Gravier, C. Kempf |
| 13 |
[GO] |
2023―Nov―14 |
The outbreak of seasonal influenza after the COVID-19 pandemic in China: Unraveling the “Immunity debt” |
Qingchun Pan, Xiaohua Chen, Yongsheng Yu, Guoqing Zang, Zhenghao Tang |
| 14 |
[GO] |
2023―Nov―10 |
The importance of COVID-19 vaccination during lactation |
Maria Isabel Valverde-Merino, Manuel Gomez-Guzman, Celia Piquer-Martinez, Maria Dolores Cabezas Lopez, Maria Jose Zarzuelo |
| 15 |
[GO] |
2023―Sep―09 |
Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - lessons to learn in long COVID? |
F.B. Løkke, K.S. Hansen, L.S. Dalgaard, K. Öbrink-Hansen, B. Schiøttz-Christensen, S. Leth |
| 16 |
[GO] |
2023―Aug―10 |
Diagnostic accuracy of a rapid antigen triple test (SARS-CoV-2, respiratory syncytial virus, and influenza) using anterior nasal swabs versus multiplex RT-PCR in children in an emergency department |
Salim Ferrani, Thierry Prazuck, Stéphane Béchet, Fabien Lesne, Robert Cohen, Corinne Levy |
| 17 |
[GO] |
2023―Jul―14 |
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19 |
Nadir Arber, Pallav L Shah, Lambert Assoumou, Casper Rokx, Nathalie De Castro, Ameet Bakhai, Alex Soriano Viladomiu, Lourdes Mateu, Carlos Lumbreras, Vicente Estrada, Adrian Curran, Pierre-Olivier Sellier, Annie Duffy, Carl Fletcher, Essy Mozaffari, Richard Haubrich, Paul Hodgkins, Anton Pozniak, Francois Raffi |
| 18 |
[GO] |
2023―Jul―14 |
Medical treatment for Covid-19 - three years later |
François Trémolières |
| 19 |
[GO] |
2023―Jul―03 |
Long COVID sexual dysfunction among both genders: evaluation of a cohort of COVID-19 recoverees |
Dana Yelin, Vered Daitch, Talya Kalfon, Michal Mor, Shira Buchrits, Yair Shafir, Muhammad Awwad, Nassem Ghantous, Irit Shapira-Lichter, Leonard Leibovici, Dafna Yahav, Ili Margalit |
| 20 |
[GO] |
2023―May―17 |
External validation of the Oldham Composite Covid-19 associated Mortality Model (OCCAM), a prognostic model for death in patients hospitalised with Covid-19 |
J.V. Thompson, J.M. Clark, T. Fincham, R. Harkness, N.J. Meghani, B.M. Powell, D. McLeneghan, G. Ng Man Kwong |
| 21 |
[GO] |
2023―Apr―26 |
Prospective cohort of COVID-19 patients requiring hospital admission in Douala, Cameroon |
S. Tchamgoué, M. Ntep Eboko, A. Makamté, A. Ngagnia, F. Talla-Mba, O. Nitcheu Wendi, E. Kafando, B. Tengang, J.P. Sandjon, P. Tattevin |
| 22 |
[GO] |
2023―Apr―11 |
Lesson from the COVID-19 pandemic lockdown: A major change of hospital-diagnosed bacteremia epidemiology |
Vincent Cauhapé, Brigitte Lamy, Romain Lotte, Irit Touitou, Laurent Boyer, Julie Contenti, François Parisot, Raymond Ruimy, Michel Carles, Johan Courjon |
| 23 |
[GO] |
2023―Mar―22 |
Risk factors for nosocomial COVID-19 in a French university hospital |
C Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, J Giai, JL Bosson, C Landelle |
| 24 |
[GO] |
2023―Mar―01 |
Emergence and Evolution of the Omicron SARS-CoV-2 Variant in the Island of Martinique |
GN Gbaguidi, L Aubert, J Schaeffer, L Fagour, A Dubremetz, Vincent Enouf, M-Hélène Glaudon-Louveau de la Guigneraye, F Nestour, J Rosine, G Dos-Santos |
| 25 |
[GO] |
2023―Feb―28 |
COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants |
Ana Hernández-Aceituno, Abigail García-Hernández, Eneko Larumbe-Zabala |
| 26 |
[GO] |
2023―Feb―25 |
Twelve-month follow-up after hospitalization for SARS-COV-2: physiology improves, symptoms remain |
Søren Sperling, Steffen Leth, Andreas Fløe, Charlotte Hyldgaard, Tina Gissel, Ayfer Topcu, Lars Kristensen, Lene Sønderskov Dahl, Johannes Martin Schmid, Søren Jensen-Fangel, Elisabeth Bendstrup |
| 27 |
[GO] |
2023―Feb―11 |
Symptoms of Long-COVID 1-Year After a COVID-19 Outbreak Among Sailors on a French Aircraft Carrier |
Anne Perisse, François De Cacqueray, David Delarbre, Hélène Marsaa, Cedric Bergmann, Virginie Da Silva, Antoine Bronstein, Nicolas Paleiron, Nastasia Menoud, Jacques Cobola, Catherine Verret, Aurélie Mayet, Olivier Bylicki |
| 28 |
[GO] |
2023―Feb―10 |
Management of imported malaria in the emergency department: adequacy compared to guidelines, and impact of the SARS-CoV-2 pandemic |
C Flateau, A Pitsch, C Cornaglia, M Picque, A de Pontfarcy, P Leroy, T Jault, C Thach, M Camus, F Dolveck, S Diamantis |
| 29 |
[GO] |
2023―Jan―23 |
Contributory conditions for unexpected COVID-19 cases and nosocomial COVID-19 infection cases identified from systematic investigation in a French university hospital |
Y. Carré, M. Coppry, C. Bataille, L. Vivier, A. Lasheras-Bauduin, A-M. Rogues |
| 30 |
[GO] |
2023―Jan―23 |
Towards real-time monitoring of COVID-19 nosocomial clusters using SARS-CoV-2 genomes in a university hospital of the French Alps |
Meghann Gallouche, Caroline Landelle, Sylvie Larrat, Aurélie Truffot, Jean-Luc Bosson, Alban Caporossi |
| 31 |
[GO] |
2023―Jan―13 |
Outpatient Parenteral Antimicrobial Therapy (OPAT) From an emergency model applied during the COVID-19 pandemic to standard of care: preliminary lessons from our experience |
G. Giuliano, F. Raffaelli, D. Faliero, E. Tamburrini, D. Tarantino, M.C. Nurchis, G. Scoppettuolo |
| 32 |
[GO] |
2023―Jan―13 |
Association between microbiota and immune response to Sars-CoV-2 infection |
A. Vitiello, A. Zovi, F. Ferrara |
| 33 |
[GO] |
2022―Dec―13 |
Spread of viruses, which measures are the most apt to control COVID-19? |
Yacine Tandjaoui-Lambiotte, Alexandra Lomont, Pierre Moenne-Locoz, Delphine Seytre, Jean Ralph Zahar |
| 34 |
[GO] |
2022―Nov―25 |
High-flow cannula for frail patients with SARS-CoV-2 infection non-eligible for intensive care unit management |
L Bouetard, T Flamand, D Vignes, A Robert, R Sterpu, L Lemonnier, M Mion, V Gerber, S Abgrall, M Martinot |
| 35 |
[GO] |
2022―Oct―30 |
Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients |
Elisa Teyssou, Stéphane Marot, Theophile Cocherie, Fauchois Antoine, Basma Abdi, Eve Todesco, Sepideh Akhavan, Valérie Pourcher, Vincent Calvez, Anne-Geneviève Marcelin, Cathia Soulie |
| 36 |
[GO] |
2022―Sep―22 |
Pharmacovigilance for COVID-19 vaccines: A 1-year experience in France |
S. Crommelynck, P. Thill |
| 37 |
[GO] |
2022―Sep―21 |
The SARS-CoV-2 vaccines: retrospective and perspectives |
Olivier Epaulard |
| 38 |
[GO] |
2022―Sep―16 |
From the original SARS-CoV-2 strain to the Omicron variant: predictors of COVID-19 in ambulatory symptomatic children |
R. Cohen, A. Rybak, N. Ouldali, F. Angoulvant, S. Béchet, V Gajdos, I. Hau, A. Sellam, I. El Aouane El Ghomari, F. Elmerich, C. Batard, A. Auvrignon, E. Grimprel, M. Favier, C. Jung, C. Levy |
| 39 |
[GO] |
2022―Sep―13 |
What progress has been made in treatment of immunocompromised COVID-19 patients? |
F. Ader, J. Bauer |
| 40 |
[GO] |
2022―Sep―13 |
Attitudes of French adults toward COVID-19 vaccination |
J.K. Ward, J. Bauer |
| 41 |
[GO] |
2022―Sep―13 |
Attitudes of healthcare professionals toward the COVID-19 vaccination campaign in France |
J.E. Mueller, J. Bauer |
| 42 |
[GO] |
2022―Sep―13 |
SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France |
R. Garlantezec, E. Tadié, C. Heslan, P. Gary-Bobo, S. Oumari, A. Saade, A. Sitruk, P. Tattevin, V. Thibault, C. Paris, Paule Le Deun, Marc Haberbusch, Annie Le Guyader, Gilles Quiboeuf, Yves Le Garzic, Nicolas Chauvel, Laurent Verley, Laetitia Goubert-Fauqueur |
| 43 |
[GO] |
2022―Sep―13 |
SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy |
B. Lina, J. Bauer |
| 44 |
[GO] |
2022―Jul―08 |
Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 season |
D. Luque-Paz, E. Orhant, F. Michel, P. Kuentz, J-F. Chapellier, E. Rolland, C. Rabaud, P. Tattevin |
| 45 |
[GO] |
2022―Jul―07 |
Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster |
G.L. Salvagno, B.M. Henry, G. Lippi |
| 46 |
[GO] |
2022―Jun―23 |
Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: the 2020-2021 and 2021-2022 seasons |
S Vaux, D Viriot, C Forgeot, I Pontais, Y Savitch, A Barondeau-Leuret, S Smadja, M Valette, V Enouf, I Parent du Chatelet |
| 47 |
[GO] |
2022―Jun―03 |
Outcome of mild SARS-CoV-2-infected renal transplant recipients managed by supervised home-based self-monitoring |
Vamsidhar Veeranki, Dharmendra Bhadauria, Jeyakumar Meyyappan, Manas Ranjan Patel, Monika Yaccha, Anupma Kaul, Sabarinath Shanmugam, Narayan Prasad |
| 48 |
[GO] |
2022―Jun―03 |
The humoral response of mRNA COVID-19 vaccine in hematological diseases: the HEMVACO study |
M Gueguen, L Khatchatourian, C Lohéac, I Dorval, M Mercier, R Le Calloch, K Mahé, MJ Rizcallah, P Hutin, MS Fangous, N Saidani, L Le Clech |
| 49 |
[GO] |
2022―May―07 |
Characteristic outcomes and risk assessment of pneumothorax in 21 patients with COVID-19 |
L Pierre, J Rieu, T Lemmet, C Ion, S Gravier, M Mohseni-Zadeh, T Lawson, V Gerber, M Martinot |
| 50 |
[GO] |
2022―May―07 |
Teleconsultation in family medicine amid the Covid-19 pandemic: an adequate tool? |
Verhaeghe Hadrien, Nelly Chellum, Benoît Tressières, Rachida Ouissa, Pierre-Marie Roger |
| 51 |
[GO] |
2022―May―07 |
High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab |
M Mandal, M Mazza, A M Esquinas |
| 52 |
[GO] |
2022―May―02 |
Determinants of the willingness to get the third COVID-19 vaccine dose among health care workers |
C Paris, A Saade, E Tadié, R Nguyen Van, V Turmel, R Garlantezec, P Tattevin |
| 53 |
[GO] |
2022―Feb―16 |
Association between SARS-Cov-2 infection during pregnancy and adverse pregnancy outcomes: a re-analysis of the data reported by Wei et al. (2021) |
Ludwig Serge Aho Glele, Emmanuel Simon, Camille Bouit, Maeva Serrand, Laurence Filipuzzi, Karine Astruc, Philippe Kadhel, Paul Sagot |
| 54 |
[GO] |
2022―Feb―14 |
Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use |
Rachida Ouissa, Chloé Le Guillou, Marion Broudic, Samuel Markowicz, Elodie Curlier, Pierre-Marie Roger |
| 55 |
[GO] |
2022―Feb―13 |
Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone |
S Benguerfi, F Reizine, F Eugène, P Tattevin, A Maamar |
| 56 |
[GO] |
2022―Feb―13 |
Factors associated with hospital admission and adverse outcome for COVID-19: role of social factors and medical care |
A-L Beaumont, D Vignes, R Sterpu, G Bussone, I Kansau, C Pignon, R Ben Ismail, M Favier, J-L Molitor, D Braham, R Fior, S Roy, M Mion, L Meyer, M Andronikof, C Damoisel, P Chagué, J-C Aurégan, N Bourgeois-Nicolaos, C Guillet-Caruba, J-P Téglas, S Abgrall |
| 57 |
[GO] |
2022―Feb―11 |
Long COVID-19 symptoms: clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
S Seang, O Itani, G Monsel, B Abdi, A-G Marcelin, M-A Valantin, R Palich, A Fayçal, V Pourcher, C Katlama, R Tubiana |
| 58 |
[GO] |
2022―Feb―08 |
3D-printed simulator for nasopharyngeal swab collection for COVID-19 |
A Koch, M Vermel, Y Hansmann, M Lodi, C Mura, A Sananes, S Gallien, É Wurtz, A Bleibtreu, M Martinot, J Exinger, X Lescure, S Kerneis, K Lacombe, JY Mootien, C Shawali, L Lecointre, C Debry, N Lefebvre, N Sananes |
| 59 |
[GO] |
2022―Feb―02 |
Are symptoms associated with SARS-CoV-2 infections evolving over time? |
M. Ricco, M. Valente, F. Marchesi |
| 60 |
[GO] |
2022―Jan―20 |
COVID-19 reinfection after pregnancy |
L Gobin, A Vallée, D Zucman, M Carbonnel, J Laperrelle, O Brugière, A Martin, JM Ayoubi, E Farfour |
| 61 |
[GO] |
2022―Jan―14 |
COVID-19 cluster in vaccinated healthcare workers in Mayotte |
L Mayrand, N Allou, F Colliac Chirié |
| 62 |
[GO] |
2021―Dec―24 |
Grippe et Covid-19 |
K. Jaffal, H. Mascitti |
| 63 |
[GO] |
2021―Dec―16 |
Vaccine effectiveness against COVID-19 hospitalization in adults in France: a test negative case control study |
Liem Binh Luong Nguyen, Rebecca Bauer, Zineb Lesieur, Florence Galtier, Xavier Duval, Philippe Vanhems, Fabrice Lainé, Pierre Tattevin, Christine Durier, Odile Launay |
| 64 |
[GO] |
2021―Dec―09 |
Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards |
M Husain, S Valayer, N Poey, E Rondinaud, C d’Humières, B Visseaux, S Lariven, FX Lescure, L Deconinck |
| 65 |
[GO] |
2021―Nov―24 |
High negative predictive value of RT-PCR in patients with high likelihood of SARS-CoV-2 infection |
S Galmiche, S Fernandes-Pellerin, MN Ungeheuer, O Schwartz, M Attia, B Hoen |
| 66 |
[GO] |
2021―Nov―17 |
Prevalence and factors associated with symptom persistence: a prospective study of 429 mild COVID-19 outpatients |
A Faycal, AL Ndoadoumgue, B Sellem, C Blanc, Y Dudoit, L Schneider, R Tubiana, M-A Valantin, S Seang, R Palich, A Bleibtreu, G Monsel, N Godefroy, O Itani, O Paccoud, V Pourcher, E Caumes, N Ktorza, A Chermak, B Abdi, L Assoumou, C Katlama |
| 67 |
[GO] |
2021―Nov―11 |
COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France |
A Velay, F Gallais, MJ Wendling, S Bayer, N Reix, A Schneider, L Glady, N Collongues, JM Lessinger, Y Hansmann, L Kling-Pillitteri, J De Sèze, M Gonzalez, C Schmidt-Mutter, N Meyer, S Fafi-Kremer |
| 68 |
[GO] |
2021―Oct―25 |
Exhaustive assessment of Reunion Island inpatients with COVID-19 during the first wave |
L Bruneau, V Lenclume, A Maillot, A Rousseau, M Lagrange-Xélot, N Allou, P Gérardin |
| 69 |
[GO] |
2021―Oct―13 |
Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France |
M Martinot, M Eyriey, S Gravier, D Kayser, C Ion, M Mohseni-Zadeh, JC Ongagna, A Schieber, C Kempf |
| 70 |
[GO] |
2021―Oct―13 |
Demographics and outcomes of laboratory-confirmed COVID-19 cases during the first epidemic wave in Senegal |
Agbogbenkou Tevi Déla-dem Lawson, Mamour Dieng, Fulgence Abdou Faye, Papa Alassane Diaw, Christian Kempf, Adama Berthe, Madoky Maguette Diop, Martin Martinot, Sylvie Audrey Diop |
| 71 |
[GO] |
2021―Oct―01 |
Comparison of the first and second waves of coronavirus disease in Toulouse, France |
A. Jourdes, M. Lafaurie, G. Moulis, P. Delobel, M. Faruch, A. Sommet, G. Martin-Blondel |
| 72 |
[GO] |
2021―Oct―01 |
Lower nasopharyngeal viral load in young SARS-CoV-2-positive subjects |
GL Salvagno, B M Henry, G Lippi |
| 73 |
[GO] |
2021―Sep―15 |
Multisystem inflammatory syndrome in an adult following COVID-19 |
G Baulier, D Jarnier, B Castan, A Saunier |
| 74 |
[GO] |
2021―Sep―04 |
Determinants of COVID-19 vaccine hesitancy in French hospitals |
C Navarre, P Roy, S Ledochowski, M Fabre, A Esparcieux, B Issartel, M Dutertre, A-L Blanc-Gruyelle, F Suy, L Adelaide, C Pariset, JP Kisterman, H Champagne, J Saison |
| 75 |
[GO] |
2021―Aug―28 |
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19 |
Erica Telford, Inmaculada Ortega-Perez, Guillaume Mellon, Boris Lacarra, Elisabeth Adjadj, Claire Madelaine, Eric D’Ortenzio, Yazdan Yazdanpanah |
| 76 |
[GO] |
2021―Aug―02 |
Consommations hospitalières en antifongiques avant et pendant la première vague de COVID-19 |
F. Lieutier-Colas, A. Jouzeau, A. Chabaud, C. Dumartin, M. Péfau, F. Botterel, A. Alanio, S. Ranque, J. Gangneux, L. Simon |
| 77 |
[GO] |
2021―Aug―02 |
La place d’une EOH à l’interface entre les différents acteurs dans le contact tracing COVID-19 |
A. Pyot, A. Provent, M. Poggio, A. Fourneret-Vivier, E. Forestier, F. Mallaval |
| 78 |
[GO] |
2021―Aug―02 |
Les engelures : un facteur pronostique associé à moins d’hospitalisations pour COVID-19 |
H. Mascitti, P. Jourdain, A. Bleibtreu, L. Jaulmes, A. Dechartres, X. Lescure, Y. Yordanov, A. Dinh |
| 79 |
[GO] |
2021―Aug―02 |
Surinfection bactérienne chez les patients hospitalisés pour COVID-19 |
S. Ben Hmida, I. Bougharriou, S. Ourida, K. Mnif, T. Ben Jemaa, K. Rekik, F. Smaoui, M. Koubaa, C. Marrakchi, M. Ben Jemaa |
| 80 |
[GO] |
2021―Aug―02 |
Surmortalité dans les maisons de retraite pendant la pandémie de COVID-19 |
S. Bessis, A. Schnitzler, H. Mascitti, C. Duran, A. Dinh |
| 81 |
[GO] |
2021―Aug―02 |
Mise en place des centres de vaccination contre la COVID-19 |
G. Mellon, J.M. Chapplain, F. Chatel, H. Coignard, C. Migerel, F.X. Lescure |
| 82 |
[GO] |
2021―Aug―02 |
« Pandecomics » : l’apport de la bande dessinée à l’ère du COVID-19 |
M. Puges, D. Neau, J.L. Pellegrin, P. Parneix, A.M. Rogues, M.E. Lafon, Y. Belaroussi, T. Le Roux, F. Guerville, C. Cazanave |
| 83 |
[GO] |
2021―Aug―02 |
« Coronaaah, c’est quoi ? » : une bande dessinée de vulgarisation scientifique sur le COVID-19 |
M. Puges, D. Neau, J.L. Pellegrin, M. Begon, A.M. Rogues, M.E. Lafon, D. Malvy, P. Blanco, P. Parneix, C. Cazanave |
| 84 |
[GO] |
2021―Aug―02 |
SYNDICORO. Implication des SMIT français dans la 1re phase de l’épidémie de COVID-19 |
C. Casas, S. Alfandari, P. Abgueguen, D. Salmon, B. Wyplosz, H. Aumaître |
| 85 |
[GO] |
2021―Aug―02 |
Caractéristiques des volontaires inscrits sur la plateforme nationale dédiée aux essais vaccinaux COVID-19 |
J. Sambourg, M. Bonneton, L. Luong, C. Trillou, T. Ngoué, J. Dohou, M. Schuers, M. Lachâtre, N. Lenzi, O. Launay |
| 86 |
[GO] |
2021―Aug―02 |
Oxygénothérapie à haut débit en hospitalisation conventionnelle de maladies infectieuses au temps de la CoVID-19 |
C. Badr, D. Jaafar, A. Bounhiol, F. Medina, J. Georger, P. Caraux-Paz |
| 87 |
[GO] |
2021―Aug―02 |
Maladie à Coronavirus (COVID-19) : connaissance, attitude et pratiques du personnel de santé |
S. Boujamline, W. Marrakchi, I. Kooli, M. Abdeljalil, H. Ben Brahim, A. Toumi, A. Aouam, M. Chakroun |
| 88 |
[GO] |
2021―Aug―02 |
Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère |
N. Peiffer-Smadja, A. Bridier-Nahmias, C. Carpentier, M. Garé, C. Rioux, A. Allemand, L. Kramer, D. Descamps, Y. Yazdanpanah, B. Visseaux |
| 89 |
[GO] |
2021―Aug―02 |
Covid-19 à La Réunion : peut-on parler d’un « confinement des pathologies » pour les passages aux urgences et les consultations en médecine libérale en 2020 ? |
J. Daoudi, M. Vincent, A. Vague, B. Guihard, I. Pontais, L. Menudier |
| 90 |
[GO] |
2021―Aug―02 |
Covid-19 à Mayotte : profil épidémiologique d’une année de crise |
M. Subiros, F. Parenton, R. Blonde, F. Pousset, A. Diallo, M. Niang, A. Chamouine, L. Iche, L. Collet, P. Combe |
| 91 |
[GO] |
2021―Aug―02 |
Évolution du taux de recours à l’antibiothérapie chez les patients hospitalisés pour COVID-19 - ANTIBIOVID 2 |
A. Thery, A. Galy, R. Lepeule, C. Ourghanlian |
| 92 |
[GO] |
2021―Aug―02 |
Comparaison des caractéristiques et de l’évolution des patients hospitalisés pour COVID-19 au cours de la première et deuxième vagues en France |
M. Martinot, M. Eyrier, S. Gravier, D. Kayser, C. Ion, M. Mohseni-Zadeh, J. Onganga, J. Kaiser, A. Schieber, C. Kempf |
| 93 |
[GO] |
2021―Aug―02 |
Transmission de la COVID-19 aux agents de santé : oé est le risque ? |
A. Lomont, N. Hassold, H. Delagreverie, S. O믪, S. Nagle, C. Alloui, J. Zahar, H. Cordel |
| 94 |
[GO] |
2021―Aug―02 |
Évaluation de l’impact de la pandémie de la COVID-19 chez les patients vivants avec le VIH |
L. Bronner, O. Robineau, F. Ajana, T. Huleux, J.L. Schmit, J.P. Lanoix, H. Bazus, E. Aissi, A. Meybeck, P. Thill |
| 95 |
[GO] |
2021―Aug―02 |
Le fardeau de la COVID-19 chez les personnes vivant avec le VIH après la première vague de la pandémie |
A. Meybeck, T. Huleux, M. Tétart, P. Thill, V. Derdour, L. Bocket, E. Alidjinou, P. Patoz, O. Robineau, F. Ajana |
| 96 |
[GO] |
2021―Aug―02 |
Étude multicentrique des déterminants à la vaccination COVID-19 chez les travailleurs hospitaliers, en établissements publics et privés |
C. Navarre, M. Fabre, A. Esparcieux, B. Issartel, M. Dutertre, A. Blanc-Gruyelle, F. Suy, L. Adelaide, H. Champagne, J. Saison |
| 97 |
[GO] |
2021―Aug―02 |
Spécificités des pneumopathies acquises sous ventilation mécanique chez les patients atteints de COVID-19 (CPAVM) : comparaison avec une cohorte historique de PAVM non COVID (NCPAVM) |
M. Rouyer, T. Youbong, A. Strazzulla, P. Leroy, A. Pitsch, C. Judel, B. Cassard, S. Jochmans, M. Monchi, S. Diamantis |
| 98 |
[GO] |
2021―Aug―02 |
Consommations d’antibiotiques pendant la première vague COVID-19 dans les établissements de santé |
A. Jouzeau, A. Chabaud, M. Péfau, L. Dugravot, F. Lieutier-Colas, L. Simon, C. Dumartin |
| 99 |
[GO] |
2021―Aug―02 |
Gestion de la pandémie COVID-19 dans les établissements scolaires : est ce que les enseignants respectent les bonnes pratiques d’hygiène ? |
N. Ketata, H. Ben Ayed, I. Masmoudi, S. Yaich, M. Baklouti, M. Al Belbissi, M. Kassis, H. Feki, J. Damak |
| 100 |
[GO] |
2021―Aug―02 |
Création d’une équipe de coordination dédiée à la vaccination Covid-19 dans les communes isolées de Guyane |
E. Jacoud, S. Teissier, V. Servas, A. Papin, F. Morandais, F. Gras, C. Michaud, M. Gaillet, N. Vignier, L. Epelboin |
| 101 |
[GO] |
2021―Aug―02 |
Difficultés et enjeux de la vaccination contre le COVID-19 dans une Guyane multiethnique et multiculturelle |
L. Epelboin, C. Michaud, B. Bidaud, L. Dudognon, C. Cochet, C. Caspar, E. Jacoud, V. Servas, N. Vignier, M. Gaillet |
| 102 |
[GO] |
2021―Aug―02 |
Attitudes vis-à-vis du vaccin COVID-19 des soignants exerçant en Guyane française |
N. Vignier, K. Brureau, S. Granier, J. Breton, C. Agostini, L. Epelboin, A. Valdes, P. Abboud, F. Djossou, M. Douine |
| 103 |
[GO] |
2021―Aug―02 |
Présentation clinique, survie et facteurs associés à la mortalité: une étude prospective dans trois centres COVID-19 en Afrique de l’Ouest |
M. Jaspard, M. Saliou Sow, S. Juchet, E. Dienderé, B. Serra, R. Kojan, A. Poda, S. Keita, X. Anglaret, D. Malvy |
| 104 |
[GO] |
2021―Aug―02 |
COVID-19 et étudiants en médecine : connaissances, attitudes et pratiques |
N. Ketata, H. Ben Ayed, M. Ben Hmida, M. Trigui, M. Ben Jmeaa, S. Yaich, M. Kassis, H. Feki, J. Damak |
| 105 |
[GO] |
2021―Aug―02 |
MicroARN en tant que biomarqueurs de la COVID-19 grave |
S. Menasria, J. Poissy, B. Guerred, M. Caplan, J. Goutay, J. Labreuche, F. Soncin, D. Hober, S. Szunerits, I. Engelmann |
| 106 |
[GO] |
2021―Aug―02 |
Analyse des consommations locales d’antibiotiques durant la première vague épidémique de COVID-19 (mars-avril 2020) dans un hôpital de référence |
L. Roquefeuil, C. Lawrence, A. Dinh, P. Bravo, M. Villart, B. Davido, F. Bouchand |
| 107 |
[GO] |
2021―Aug―02 |
La communication destinée aux professionnels de santé au cœur de la gestion de crise de la pandémie de COVID-19 par le ministère des Solidarités et de la Santé |
M. Rigaud, L. Prevost Sansac de Traversay, M. Creach, C. Lazarus, J. Salomon |
| 108 |
[GO] |
2021―Aug―02 |
Forme sévère de COVID-19 pendant la première vague épidémique en France : rôle des facteurs sociaux et des traitements empiriques |
A. Beaumont, D. Vignes, R. Sterpu, S. Roy, C. Guillet-Caruba, J. Téglas, S. Abgrall |
| 109 |
[GO] |
2021―Aug―02 |
Mise en relation entre l’évolution clinique et scanographique des patients atteints de la COVID-19 sévère ou critique traités par glucocorticoïdes |
A. Courdurié, M. Juston, P. Foglino, E. Demonchy |
| 110 |
[GO] |
2021―Aug―02 |
Impact de l’épidémie de COVID-19 sur la couverture vaccinale antigrippale du personnel hospitalier |
A. Gronnwald, V. Gerber, C. Hommel, D. Eckenfelder, O. Meunier, A. Sondag, P. Lefebvre, M. Martinot, M. Mohseni-Zadeh |
| 111 |
[GO] |
2021―Aug―02 |
Bilan des signalements COVID-19 sur la plateforme e-SIN, France, 2020 |
P. Toulemonde, I. Poujol, S. Soing-Altrach, A. Léon, A. Berger-Carbonne |
| 112 |
[GO] |
2021―Aug―02 |
Impact de la pandémie de COVID-19 sur la résistance aux antibiotiques en soins de ville et en Ehpad en France |
O. Lemenand, T. Coeffic, S. Thibaut, J. Caillon, G. Birgand |
| 113 |
[GO] |
2021―Aug―02 |
Influence de la pandémie de la COVID-19 sur le dépistage de l’infection par le VIH |
O. Da Conceicao, M. Digumber, S. Le Gac, B. Phung, A. Bachard, R. Landman, F. Damond, J. Ghosn, Y. Yazdanpanah, V. Joly |
| 114 |
[GO] |
2021―Aug―02 |
Impact post-déconfinement de la pandémie de COVID-19 sur les patients chroniques en Europe |
A. Astruc, B. Halioua, J. Zetlaoui, M. Harrizi, A. Bombezin-Domino, L. Radoszycki |
| 115 |
[GO] |
2021―Aug―02 |
Impact de la pandémie de COVID-19 sur les populations sans domicile fixe : résultats d’une cohorte fermée rétrospective (mars-mai 2020) |
M. Husain, A. Rachline, A. Cousien, S. Rolland, V. Ferre, M. Wicky-Thisse, D. Descamps, Y. Yazdanpanah, C. Charpentier, A. Pasquet-Cadre |
| 116 |
[GO] |
2021―Aug―02 |
Impact de la pandémie à COVID-19 sur les voyages internationaux |
K. Jidar, G. Benabdelmoumen, C. Lucet, P. Poujol, L. Kuhmel, J. Leporrier, P. Consigny |
| 117 |
[GO] |
2021―Aug―02 |
Suivi ambulatoire des patients COVID-19 via l’application MH LINK |
A. Martin, E. Nogue, M. Morell, J. Reynes, V. Le Moing, M. Picot, A. Makinson |
| 118 |
[GO] |
2021―Aug―02 |
Intérêt du passage précoce d’un référent infectieux sur l’exposition aux antibiotiques des patients hospitalisés pour COVID-19 - ANTIBIOVID |
A. Galy, C. Ourghanlian, S. Fourati, S. Gallien, G. Melica, W. Vindrios, C. Guillaud, V. Fihman, M. Harrabi, R. Lepeule |
| 119 |
[GO] |
2021―Aug―02 |
Consommation d’antibiotiques à l’ère de la COVID-19 : analyse et comparaison entre la 1re et 2e vague |
C. Meunier, D. Neau, M. Puges, C. Cazanave, A. Desclaux |
| 120 |
[GO] |
2021―Aug―02 |
Prévention COVID-19 : du dépistage à la vaccination « hors les murs (HLM) » |
M. Ruffin, M. Roy, A. Eden, J. Cornaglia, H. Aumaître |
| 121 |
[GO] |
2021―Aug―02 |
Pneumopathies acquises sous ventilation mécanique (PAVM) chez les patients atteints de COVID-19 : facteurs associés à la mortalité |
M. Rouyer, T. Youbong, A. Strazzulla, P. Tarteret, S. Devatine, A. Pitsch, B. Cassard, S. Jochmans, M. Monchi, S. Diamantis |
| 122 |
[GO] |
2021―Aug―02 |
Gestion de la COVID-19 : perceptions et expériences des personnels de nuit lors de la première vague de la pandémie dans les hôpitaux publics parisiens (enquête AP-HP ALADDIN) |
M. Duracinsky, L. Cousin, O. Rousset Torrente, V. Di Beo, V. Mahé, P. Carrieri, F. Marcellin, O. Chassany |
| 123 |
[GO] |
2021―Aug―02 |
Évaluation de l’efficacité d’une stratégie multimodale sur les connaissances et les perceptions des professionnels de santé en matière d’hygiène des mains en phase pandémique COVID-19 : une étude quasi-expérimentale |
H. Maamri, H. Ben Ayed, N. Ketata, M. Baklouti, S. Yaich, H. Feki, J. Damak |
| 124 |
[GO] |
2021―Aug―02 |
Les patients infectés par le VIH sont-ils défiants vis-à-vis de la vaccination COVID-19 ? |
M.A. Khuong-Josses, C. Charpentier, M. Poupard |
| 125 |
[GO] |
2021―Aug―02 |
Quelles particularités des manifestations digestives de la COVID-19 ? |
K. Mnif, F. Smaoui, S. Ben Hmida, H. Hana Chaabouni, F. Gassara, K. Rekik, M. Koubaa, C. Marrakchi, M. Ben Jemaa |
| 126 |
[GO] |
2021―Aug―02 |
Présentation clinique des patients présentant des symptômes persistants après un épisode documenté ou non documenté d’infection par le SARS-CoV-2 |
D. Slama, M. Ben Azaiez, O. Robineau, V. Le Baut, T. de Broucker, C. Hautefort, E. Pichard, D. Salmon |
| 127 |
[GO] |
2021―Aug―02 |
EndoNUclease Heteroduplex Cleavage typing (ENUHCT) : une technique universelle de typage avec concept de preuve sur la détection des variants de spike du SARS-CoV-2 |
E. Lopez, B. Coutard, B. Lina, A. Falchi, X. de Lamballerie, R. Charrel |
| 128 |
[GO] |
2021―Aug―02 |
Facteurs associés à l’infection par le SARS-CoV-2, étude de cohorte de personnes en situation de sans-abrisme |
E. Mosnier, S. Loubière, E. Monfardini, A. Alibert, J. Landier, L. Ninoves, T. Bosetti, M. Mosnier, S. Nguengang Wakap, A. Tinland |
| 129 |
[GO] |
2021―Aug―02 |
Séroprévalence SARS-CoV-2 au Mali : résultats d’une enquête transversale |
M. Cissoko, J. Landier, M. Bendiane, A. Sangaré, A. Katile, I. Berthé, I. Théra, B. Kouriba, J. Gaudart, I. Sagara |
| 130 |
[GO] |
2021―Aug―02 |
Réponse à la vaccination contre le SARS-CoV-2 chez des patients hémodialysés chroniques |
M. Monge, C. Richaud, M. De Laroche, M. Lefevre, S. Camps, F. Compain |
| 131 |
[GO] |
2021―Aug―02 |
Étude de l’expression du CD169 sur les monocytes comme biomarqueurs des infections virales notamment le SARS-CoV-2 chez l’enfant |
L. Domitien, A. Bedin, E. Tuaillon, E. Jeziorski |
| 132 |
[GO] |
2021―Aug―02 |
Séroprévalence SARS-Cov-2 chez les professionnels de santé : étude multicentrique avec analyse des facteurs de risque professionnels et extraprofessionnels |
V. Vitrat, A. Maillard, A. Raybaud, C. Wackenheim, B. Chanzy, S. Nguyen, A. Valran, A. Bosch, M. Noret, T. Delory |
| 133 |
[GO] |
2021―Aug―02 |
Persistance et protection des anticorps neutralisants 12 mois après l’infection à SARS-COV-2 chez les sujets âgés |
R. Collarino, C. Vauloup-Fellous, A. Allemang-Trivalle, L. Mouna, E. Duron, M. Neiss, Z. Trikha, M. Guichardon, A. Roque, C. Trivalle |
| 134 |
[GO] |
2021―Aug―02 |
Dépistage du personnel de santé exposé au SARS-CoV-2 dans un hôpital universitaire |
L. Noel, E. Marion, R. Boufercha, F. Martin, C. Zandotti, R. Charrel, M. Bouhadfane, M. Lehucher-Michel, A. Villa |
| 135 |
[GO] |
2021―Aug―02 |
Optiflow® et SARS-CoV-2 en réanimation : facteurs de risque de recours à la ventilation mécanique et devenir des patients |
X. Leroux, M. Schock, H. Lessire, C. Bouterra, L. Belilita, P. Rerat, M. Martinot, A. Alvarez, V. Gerber |
| 136 |
[GO] |
2021―Aug―02 |
Pneumothorax et SARS-CoV-2 : analyse rétrospective de 18 cas |
L. Pierre, V. Gerber, J. Rieu, T. Lemmet, C. Ion, D. Kayser, S. Gravier, M. Martinot |
| 137 |
[GO] |
2021―Aug―02 |
Des conditions hivernales froides et sèches favorisent la transmission du SARS-CoV-2 : une analyse régionale de la première vague dans six pays occidentaux |
J. Landier, J. Paireau, S. Rebaudet, E. Legendre, L. Lehot, A. Fontanet, S. Cauchemez, J. Gaudart |
| 138 |
[GO] |
2021―Aug―02 |
Caractéristiques cliniques et devenir des patients de 75 ans et plus patients atteints d’une infection à SARS-CoV2 |
J. Mabile, E. Bernachon, A. Markiewicz, R. Hequette |
| 139 |
[GO] |
2021―Aug―02 |
Professionnels en établissements de santé infectés par le SARS-COV2 : le bilan après un an de pandémie |
G. Ben Hmidene, M. Colomb-Cotinat, S. Vaux, C. Olivier, N. Floret, F. Golliot, G. Pellissier, E. Rouveix, D. Abiteboul, A. Berger-Carbonne |
| 140 |
[GO] |
2021―Jul―28 |
Herpesvirus reactivation during severe COVID-19 and high rate of immune defect |
A Saade, G Moratelli, E Azoulay, M Darmon |
| 141 |
[GO] |
2021―Jul―13 |
Assessment of SARS-CoV-2 testing in children during a low prevalence period (VIGIL study 1) |
Eleonore Eskander, Camille Jung, Corinne Levy, Stéphane Béchet, Nathalie Blot, Stéphanie Gorde, Camille le Stradic, Matthieu Come, Robert Touitou, Robert Cohen |
| 142 |
[GO] |
2021―Jul―07 |
Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients |
M Martinot, M Eyriey, S Gravier, T Bonijoly, D Kayser, C Ion, M Mohseni Zadeh, S Camara, J Dubois, E Haerrel, J Drouaine, J Kaiser, JC Ongagna, A Schieber-Pachart, C Kempf |
| 143 |
[GO] |
2021―Jul―07 |
Burden of COVID-19 on workers in hospital settings: the French situation during the first wave of the pandemic |
M. Colomb-Cotinat, I. Poujol, S. Monluc, S. Vaux, C. Olivier, S. Le Vu, N. Floret, F. Golliot, A. Berger-Carbonne, the Geres-study group |
| 144 |
[GO] |
2021―Jul―06 |
Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers? |
G Pean De Ponfilly, B Pilmis, I El Kaibi, N Castreau, S Laplanche, A Le Monnier |
| 145 |
[GO] |
2021―Jun―29 |
Tocilizumab and COVID-19: timing of administration assessment |
Q Richier, V Jachiet, V Bonnemains, L Plaçais, N Abisror, M Garnier, J Pacanowski, R Dhote, O Hinchschberger, M Michel, B Bienvenu, C Comarmond, K Lacombe, A Mekinian |
| 146 |
[GO] |
2021―Jun―17 |
Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia |
Hanifi Yildiz, Hamit Hakan Alp, Selami Ekin, Ahmet Arisoy, Hülya Günbatar, Selvi Aşker, Buket Mermit Çilingir, Aysel Sünnetcioğlu, Maşuk Çelikel, Nevzat Esen, Serhat Bedirhanoğlu, Delal Nuruban Baykal, Mine Haylu |
| 147 |
[GO] |
2021―Jun―16 |
Are the conditions met to make COVID-19 vaccination mandatory for healthcare professionals? |
Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers, Odile Launay |
| 148 |
[GO] |
2021―May―21 |
How can SARS-CoV-2 airborne transmission ensure effective protection of healthcare workers? A review of the literature |
Sara Romano-Bertrand, Yolène Carré, Ludwig-Serge Aho Glélé, Didier Lepelletier |
| 149 |
[GO] |
2021―May―14 |
Broad-based SARS-CoV-2 Testing Program for Healthcare Workers in a Primary Care Hospital In France |
Julie Chas, Marine Nadal, Martin Siguier, Anne Fajac, Michel Denis, Laurence Morand-Joubert, Gilles Pialoux |
| 150 |
[GO] |
2021―May―12 |
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? |
Robert Cohen, Marion Ashman, Muhamed-Kheir Taha, Emmanuelle Varon, François Angoulvant, Corinne Levy, Alexis Ryback, Naim Ouldali, Nicole Guiso, Emmanuel Grimprel |
| 151 |
[GO] |
2021―May―05 |
COVID-19 vaccine hesitancy among healthcare workers |
Christophe Paris, François Bénézit, Mareva Geslin, Elisabeth Polard, Marion Baldeyrou, Valérie Turmel, Émilie Tadié, Ronan Garlantezec, Pierre Tattevin |
| 152 |
[GO] |
2021―Mar―27 |
Screening around a COVID-19 cluster: Exploring its impact on a local virus outbreak |
Gaelle Gault, Olivier Monpierre, Gaetane Carion, Patrick Rispal, Helene Royer, Marie-Edith Lafon, Daniel Habold, Laurent Filleul |
| 153 |
[GO] |
2021―Mar―23 |
Olfactory and gustatory dysfunctions in COVID-19 outpatients: a prospective cohort study |
L. Cousyn, B. Sellem, R. Palich, D. Bendetowicz, R. Agher, C. Delorme, R. Tubiana, M-A. Valantin, S. Seang, L. Schneider, A. Fayçal, Y. Dudoit, B. Abdi, A. Ndoadoumgue, L. Assoumou, C. Katlama |
| 154 |
[GO] |
2021―Mar―19 |
Outcomes of newborns to mothers with COVID-19 |
K Ghema, M Lehlimi, H Toumi, A Badre, M Chemsi, A Habzi, S Benomar |
| 155 |
[GO] |
2021―Mar―14 |
Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch |
Boris Lacarra, Guillaume Mellon, Inmaculada Ortega Perez, Eric D’Ortenzio, François-Xavier Lescure |
| 156 |
[GO] |
2021―Mar―14 |
Mosaic vaccination schedule: an unexpected card to play against SARS-CoV-2? |
Ricco Matteo, De Nard Francesca, Peruzzi Simona |
| 157 |
[GO] |
2021―Feb―27 |
Covid-19 vaccines: frequently asked questions and updated answers |
M. Lefebvre, N. Vignier, B. Pitard, E. Botelho-Nevers, R. Cohen, O. Epaulard |
| 158 |
[GO] |
2021―Feb―07 |
Clinical case definition of COVID-19 and morbid obesity: Is it time to move on? |
Valente Marina, Ricco Matteo, Tartamella Francesco, Petracca Gabriele Luciano, Dalmonte Giorgio, Fabbi Diletta, Marchesi Federico |
| 159 |
[GO] |
2021―Feb―07 |
BCG vaccination and COVID-19: Was flattening the curve just an illusion? |
Matteo Ricco, Silvia Ranzieri |
| 160 |
[GO] |
2021―Jan―27 |
Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a Severe Acute Respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient |
Anne-Pauline Bellanger, Jean-Christophe Navellou, Quentin Lepiller, Annie Brion, Anne-Sophie Brunel, Laurence Millon, Ana Berceanu |
| 161 |
[GO] |
2021―Jan―22 |
COVID-19: The Forgotten Cases of Hidden Exiles |
Clément Le Bihan, Vincent Faucherre, Vincent Le Moing, Aurélie Mehenni, Damien Nantes, Antonio Da Silva, Cyril Jaume, Fabienne Lassalle, Alain Makinson |
| 162 |
[GO] |
2021―Jan―19 |
Clinical, biological and radiological features, 4-week outcomes and prognostic factors in COVID-19 elderly inpatients |
R. Palich, Y. Wakim, O. Itani, O. Paccoud, S. Boussouar, M. Lévy-Soussan, C. Soulie, N. Godefroy, A. Bleibtreu |
| 163 |
[GO] |
2021―Jan―19 |
The Role of Infectious Disease trainees during the first wave of the COVID-19 pandemic: a national survey |
Kevin Bouiller, Gaud Catho, Marion Le Maréchal, Julien Gras, Maxime Hentzien, Nathan Peiffer-Smadja |
| 164 |
[GO] |
2021―Jan―19 |
Invasive Aspergillosis Associated with severe COVID-19: A Word of Caution |
Laura Gouzien, Theophile Cocherie, Odile Eloy, Stéphane Legriel, Jean-Pierre Bedos, Christelle Simon, Stephanie Marque-Juillet, Alexis Ferré, Fabrice Bruneel |
| 165 |
[GO] |
2021―Jan―19 |
Psychological impact of the SARS-CoV-2 outbreak on the staff of a French hospital |
C. Flateau, C. Noël, A. Bonnafoux, E. Fuentes, A de Pontfarcy, S. Diamantis |
| 166 |
[GO] |
2021―Jan―19 |
Novel pathogens, same old habits. A call for evidence-based research in the fight against COVID-19 |
Claudio Legnani, Claudio Legnani, Elisa Dusi |
| 167 |
[GO] |
2021―Jan―19 |
High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically-ill patients with Covid-19 |
Arthur Simonnet, Ilka Engelmann, Anne-Sophie Moreau, Bruno Garcia, Sophie Six, Ahmed El Kalioubie, Laurent Robriquet, Didier Hober, Mercé Jourdain |
| 168 |
[GO] |
2021―Jan―19 |
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population |
Nathanael Lapidus, Juliette Paireau, Daniel Levy-Bruhl, Xavier de Lamballerie, Gianluca Severi, Mathilde Touvier, Marie Zins, Simon Cauchemez, Fabrice Carrat |
|
